Lispro Mix 25 vs. Glargine in Type 2 Diabetics

Clinical trial NCT00551356 · COMPLETED

Trial details

NCT number: NCT00551356
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus Type 2

Start date: 2002-11-01
Enrollment: 53

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.